• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Predictors of mortality after transjugular portosystemic shunt.经颈静脉肝内门体分流术后死亡的预测因素。
World J Hepatol. 2016 Apr 18;8(11):520-9. doi: 10.4254/wjh.v8.i11.520.
2
Right atrial pressure may impact early survival of patients undergoing transjugular intrahepatic portosystemic shunt creation.右心房压力可能会影响接受经颈静脉肝内门体分流术患者的早期生存率。
Ann Hepatol. 2014 Jul-Aug;13(4):411-9.
3
Shear wave elastography prior to transjugular intrahepatic portosystemic shunt may predict the decrease in hepatic vein pressure gradient.经颈静脉肝内门体分流术前行剪切波弹性成像可能预测肝静脉压力梯度下降。
Abdom Radiol (NY). 2019 Mar;44(3):1127-1134. doi: 10.1007/s00261-018-1795-6.
4
Transjugular Intrahepatic Portosystemic Shunt Through the Strut of a Previously Placed Stent: Technical Feasibility and Long-Term Follow-Up Results.经先前放置支架的支柱进行经颈静脉肝内门体分流术:技术可行性及长期随访结果
Cardiovasc Intervent Radiol. 2018 Nov;41(11):1794-1798. doi: 10.1007/s00270-018-2033-x. Epub 2018 Jul 16.
5
Short- and long-term hemodynamic effects of transjugular intrahepatic portosystemic shunts: a Doppler/manometric correlative study.经颈静脉肝内门体分流术的短期和长期血流动力学效应:一项多普勒/测压相关性研究。
AJR Am J Roentgenol. 1995 Apr;164(4):997-1002. doi: 10.2214/ajr.164.4.7726065.
6
Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience.经颈静脉肝内门体分流术治疗顽固性腹水:单中心经验
Scand J Gastroenterol. 2012 Dec;47(12):1494-500. doi: 10.3109/00365521.2012.703239. Epub 2012 Sep 10.
7
Different scoring systems in predicting survival in Chinese patients with liver cirrhosis undergoing transjugular intrahepatic portosystemic shunt.不同评分系统对接受经颈静脉肝内门体分流术的中国肝硬化患者生存情况的预测
Eur J Gastroenterol Hepatol. 2014 Aug;26(8):853-60. doi: 10.1097/MEG.0000000000000134.
8
Older patient age may predict early mortality after transjugular intrahepatic portosystemic shunt creation in individuals at intermediate risk.老年患者年龄可能预示着中危个体经颈静脉肝内门体分流术治疗后的早期死亡率。
J Vasc Interv Radiol. 2013 Jul;24(7):941-6. doi: 10.1016/j.jvir.2013.03.018. Epub 2013 May 23.
9
MELD or Sodium MELD: A Comparison of the Ability of Two Scoring Systems to Predict Outcomes After Transjugular Intrahepatic Portosystemic Shunt Placement.MELD 或 Sodium MELD:两种评分系统预测经颈静脉肝内门体分流术放置后结局的能力比较。
AJR Am J Roentgenol. 2020 Jul;215(1):215-222. doi: 10.2214/AJR.19.21726. Epub 2020 May 20.
10
Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.肝细胞癌合并门静脉高压患者经颈静脉肝内门体分流术后肝性脑病的危险因素
J Gastrointestin Liver Dis. 2015 Sep;24(3):301-7. doi: 10.15403/jgld.2014.1121.243.yao.

引用本文的文献

1
Hepatic hydrothorax.肝性胸水
J Thorac Dis. 2024 Feb 29;16(2):1662-1673. doi: 10.21037/jtd-23-1649. Epub 2024 Feb 23.
2
Development of a new Cox model for predicting long-term survival in hepatitis cirrhosis patients underwent transjugular intrahepatic portosystemic shunts.一种用于预测接受经颈静脉肝内门体分流术的肝硬化患者长期生存的新Cox模型的开发。
World J Gastrointest Surg. 2024 Feb 27;16(2):491-502. doi: 10.4240/wjgs.v16.i2.491.
3
A Comprehensive Review of Transjugular Intrahepatic Portosystemic Shunt-Related Complications.经颈静脉肝内门体分流术相关并发症的综合综述
Semin Intervent Radiol. 2023 May 4;40(1):55-72. doi: 10.1055/s-0043-1767670. eCollection 2023 Feb.
4
The Portosystemic Shunt for the Control of Variceal Bleeding in Cirrhotic Patients: Past and Present.门体分流术治疗肝硬化患者静脉曲张出血:过去和现在。
Can J Gastroenterol Hepatol. 2022 Sep 17;2022:1382556. doi: 10.1155/2022/1382556. eCollection 2022.
5
Beyond MELD Predictors of Post TIPSS Acute Liver Failure the Lesson Learned.经颈静脉肝内门体分流术(TIPSS)后急性肝衰竭的MELD评分之外的预测因素:经验教训
Indian J Radiol Imaging. 2021 Nov 13;31(3):618-622. doi: 10.1055/s-0041-1736403. eCollection 2021 Jul.
6
Renal-function change after transjugular intra-hepatic portosystemic shunt placement and its relationship with survival: a single-center experience.经颈静脉肝内门体分流术放置后的肾功能变化及其与生存的关系:单中心经验
Gastroenterol Rep (Oxf). 2020 Dec 3;9(4):306-312. doi: 10.1093/gastro/goaa081. eCollection 2021 Aug.
7
North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension.北美门静脉高压经颈静脉肝内门体分流术实践推荐
Clin Gastroenterol Hepatol. 2022 Aug;20(8):1636-1662.e36. doi: 10.1016/j.cgh.2021.07.018. Epub 2021 Jul 15.
8
A Case Report of Portopulmonary Hypertension Precipitated by Transjugular Intrahepatic Portosystemic Shunt.经颈静脉肝内门体分流术诱发的肝肺高血压病例报告。
Chest. 2021 Apr;159(4):e193-e196. doi: 10.1016/j.chest.2020.11.014. Epub 2021 Apr 6.
9
Cirrhotic patients and older people.肝硬化患者和老年人。
World J Hepatol. 2019 Sep 27;11(9):663-677. doi: 10.4254/wjh.v11.i9.663.
10
Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma.经颈静脉肝内门体分流术联合姑息治疗在肝细胞癌患者中的安全性和有效性
World J Clin Cases. 2019 Jul 6;7(13):1599-1610. doi: 10.12998/wjcc.v7.i13.1599.

本文引用的文献

1
Right atrial pressure may impact early survival of patients undergoing transjugular intrahepatic portosystemic shunt creation.右心房压力可能会影响接受经颈静脉肝内门体分流术患者的早期生存率。
Ann Hepatol. 2014 Jul-Aug;13(4):411-9.
2
Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial.覆膜与非覆膜支架在经颈静脉肝内门体分流术中的应用:一项随机对照试验。
J Hepatol. 2014 May;60(5):962-8. doi: 10.1016/j.jhep.2014.01.015. Epub 2014 Jan 27.
3
Acute pulmonary hypertension after transjugular intrahepatic portosystemic shunt: a potentially deadly but commonly forgotten complication.经颈静脉肝内门体分流术后急性肺动脉高压:一种潜在致命但常被遗忘的并发症。
Gastroenterol Nurs. 2014 Jan-Feb;37(1):33-8; quiz 39-40. doi: 10.1097/SGA.0000000000000016.
4
Older patient age may predict early mortality after transjugular intrahepatic portosystemic shunt creation in individuals at intermediate risk.老年患者年龄可能预示着中危个体经颈静脉肝内门体分流术治疗后的早期死亡率。
J Vasc Interv Radiol. 2013 Jul;24(7):941-6. doi: 10.1016/j.jvir.2013.03.018. Epub 2013 May 23.
5
Comprehensive review of TIPS technical complications and how to avoid them.经颈静脉肝内门体分流术技术并发症的全面综述及如何预防。
AJR Am J Roentgenol. 2011 Mar;196(3):675-85. doi: 10.2214/AJR.10.4819.
6
Short-term effects of transjugular intrahepatic shunt on cardiac function assessed by cardiac MRI: preliminary results.经颈静脉肝内门体分流术对心脏功能的短期影响的心脏 MRI 评估:初步结果。
Cardiovasc Intervent Radiol. 2010 Apr;33(2):290-6. doi: 10.1007/s00270-009-9696-2.
7
The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt.使用E/A比值作为经颈静脉肝内门体分流术治疗的肝硬化患者预后的预测指标。
Am J Gastroenterol. 2009 Oct;104(10):2458-66. doi: 10.1038/ajg.2009.321. Epub 2009 Jun 16.
8
Cardiovascular complications of cirrhosis.肝硬化的心血管并发症
Postgrad Med J. 2009 Jan;85(999):44-54. doi: 10.1136/gut.2006.112177.
9
TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients.布加综合征的治疗技巧:124例患者的长期结果及预后因素
Gastroenterology. 2008 Sep;135(3):808-15. doi: 10.1053/j.gastro.2008.05.051. Epub 2008 May 21.
10
Cardiovascular determinants of survival in cirrhosis.肝硬化患者生存的心血管决定因素
Gut. 2007 Jun;56(6):746-8. doi: 10.1136/gut.2006.112169.

经颈静脉肝内门体分流术后死亡的预测因素。

Predictors of mortality after transjugular portosystemic shunt.

作者信息

Ascha Mona, Abuqayyas Sami, Hanouneh Ibrahim, Alkukhun Laith, Sands Mark, Dweik Raed A, Tonelli Adriano R

机构信息

Mona Ascha, Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, OH 44195, United States.

出版信息

World J Hepatol. 2016 Apr 18;8(11):520-9. doi: 10.4254/wjh.v8.i11.520.

DOI:10.4254/wjh.v8.i11.520
PMID:27099653
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4832094/
Abstract

AIM

To investigate if echocardiographic and hemodynamic determinations obtained at the time of transjugular intrahepatic portosystemic shunt (TIPS) can provide prognostic information that will enhance risk stratification of patients.

METHODS

We reviewed medical records of 467 patients who underwent TIPS between July 2003 and December 2011 at our institution. We recorded information regarding patient demographics, underlying liver disease, indication for TIPS, baseline laboratory values, hemodynamic determinations at the time of TIPS, and echocardiographic measurements both before and after TIPS. We recorded patient comorbidities that may affect hemodynamic and echocardiographic determinations. We also calculated Model for End-stage Liver Disease (MELD) score and Child Turcotte Pugh (CTP) class. The following pre- and post-TIPS echocardiographic determinations were recorded: Left ventricular ejection fraction, right ventricular (RV) systolic pressure, subjective RV dilation, and subjective RV function. We recorded the following hemodynamic measurements: Right atrial (RA) pressure before and after TIPS, inferior vena cava pressure before and after TIPS, free hepatic vein pressure, portal vein pressure before and after TIPS, and hepatic venous pressure gradient (HVPG).

RESULTS

We reviewed 418 patients with portal hypertension undergoing TIPS. RA pressure increased by a mean ± SD of 4.8 ± 3.9 mmHg (P < 0.001), HVPG decreased by 6.8 ± 3.5 mmHg (P < 0.001). In multivariate linear regression analysis, a higher MELD score, lower platelet count, splenectomy and a higher portal vein pressure were independent predictors of higher RA pressure (R = 0.55). Three variables predicted 3-mo mortality after TIPS in a multivariate analysis: Age, MELD score, and CTP grade C. Change in the RA pressure after TIPS predicted long-term mortality (per 1 mmHg change, HR = 1.03, 95%CI: 1.01-1.06, P < 0.012).

CONCLUSION

RA pressure increased immediately after TIPS particularly in patients with worse liver function, portal hypertension, emergent TIPS placement and history of splenectomy. The increase in RA pressure after TIPS was associated with increased mortality. Age, splenectomy, MELD score and CTP grade were independent predictors of long-term mortality after TIPS.

摘要

目的

探讨经颈静脉肝内门体分流术(TIPS)时获得的超声心动图和血流动力学测定结果能否提供预后信息,以加强对患者的风险分层。

方法

我们回顾了2003年7月至2011年12月在我院接受TIPS的467例患者的病历。我们记录了患者的人口统计学信息、潜在肝病、TIPS的适应证、基线实验室值、TIPS时的血流动力学测定结果以及TIPS前后的超声心动图测量值。我们记录了可能影响血流动力学和超声心动图测定结果的患者合并症。我们还计算了终末期肝病模型(MELD)评分和Child-Turcotte-Pugh(CTP)分级。记录了以下TIPS前后的超声心动图测定结果:左心室射血分数、右心室(RV)收缩压、主观RV扩张和主观RV功能。我们记录了以下血流动力学测量值:TIPS前后的右心房(RA)压力、TIPS前后的下腔静脉压力、游离肝静脉压力、TIPS前后的门静脉压力以及肝静脉压力梯度(HVPG)。

结果

我们回顾了418例接受TIPS的门静脉高压患者。RA压力平均升高±标准差为4.8±3.9 mmHg(P<0.001),HVPG降低6.8±3.5 mmHg(P<0.001)。在多变量线性回归分析中,较高的MELD评分、较低的血小板计数、脾切除术和较高的门静脉压力是RA压力升高的独立预测因素(R=0.55)。多变量分析中三个变量预测了TIPS后3个月的死亡率:年龄、MELD评分和CTP分级C。TIPS后RA压力的变化预测长期死亡率(每变化1 mmHg,HR=1.03,95%CI:1.01-1.06,P<0.012)。

结论

TIPS后RA压力立即升高,尤其是在肝功能较差、门静脉高压、急诊TIPS置入和有脾切除术史的患者中。TIPS后RA压力升高与死亡率增加相关。年龄、脾切除术、MELD评分和CTP分级是TIPS后长期死亡率的独立预测因素。